Efficacy of Anti-HER2 Agents in Combination With Adjuvant or Neoadjuvant Chemotherapy for Early and Locally Advanced HER2-Positive Breast Cancer Patients: A Network Meta-Analysis

BACKGROUND: Several (neo)adjuvant treatments for patients with HER2-positive breast cancer have been compared in different randomized clinical trials. Since it is not feasible to conduct adequate pairwise comparative trials of all these therapeutic options, network meta-analysis offers an opportunit...

Descripción completa

Detalles Bibliográficos
Autores principales: Debiasi, Márcio, Polanczyk, Carisi A., Ziegelmann, Patrícia, Barrios, Carlos, Cao, Hongyuan, Dignam, James J., Goss, Paul, Bychkovsky, Brittany, Finkelstein, Dianne M., Guindalini, Rodrigo S., Filho, Paulo, Albuquerque, Caroline, Reinert, Tomás, de Azambuja, Evandro, Olopade, Olufunmilayo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972314/
https://www.ncbi.nlm.nih.gov/pubmed/29872641
http://dx.doi.org/10.3389/fonc.2018.00156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972314/
https://www.ncbi.nlm.nih.gov/pubmed/29872641
http://dx.doi.org/10.3389/fonc.2018.00156

Ejemplares similares